Prevalence of and Risk Factors for Hepatic Steatosis and Nonalcoholic Fatty Liver Disease in People With Type 2 Diabetes: the Edinburgh Type 2 Diabetes Study
暂无分享,去创建一个
P. Hayes | J. Price | B. Frier | R. Reynolds | M. Strachan | R. Williamson | S. Glancy | L. Nee | E. Perry | G. I. Johnston | L. van Look | J. Price
[1] J. Price,et al. P2-202 Thiazolidinediones are associated with regression of hepatosteatosis in people with type 2 diabetes: the Edinburgh type 2 diabetes study , 2011, Journal of Epidemiology & Community Health.
[2] P. Hayes,et al. The use of ultrasound to diagnose hepatic steatosis in type 2 diabetes: intra- and interobserver variability and comparison with magnetic resonance spectroscopy. , 2011, Clinical radiology.
[3] D. Kivlahan,et al. The AUDIT Alcohol Consumption Questions (AUDIT-C) An Effective Brief Screening Test for Problem Drinking , 2010 .
[4] R. Marioni,et al. Association Between Raised Inflammatory Markers and Cognitive Decline in Elderly People With Type 2 Diabetes , 2009, Diabetes.
[5] F. Magkos,et al. Methods for assessing intrahepatic fat content and steatosis , 2009, Current opinion in clinical nutrition and metabolic care.
[6] Rebecca M Reynolds,et al. The Edinburgh Type 2 Diabetes Study: study protocol , 2008, BMC endocrine disorders.
[7] C. Selmi,et al. Clinical features and management of primary biliary cirrhosis. , 2008, World journal of gastroenterology.
[8] R. Heine,et al. Prevalence of Nonalcoholic Fatty Liver Disease and Its Association With Cardiovascular Disease Among Type 2 Diabetic Patients , 2007, Diabetes Care.
[9] P. Trombini,et al. Ferritin, metabolic syndrome and NAFLD: elective attractions and dangerous liaisons. , 2007, Journal of hepatology.
[10] J. Hardies,et al. A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis. , 2006, The New England journal of medicine.
[11] Mark Fishbein,et al. Hepatic MRI for Fat Quantitation: Its Relationship to Fat Morphology, Diagnosis, and Ultrasound , 2005, Journal of clinical gastroenterology.
[12] G. Marchesini,et al. A Randomized Controlled Trial of Metformin versus Vitamin E or Prescriptive Diet in Nonalcoholic Fatty Liver Disease , 2005, The American Journal of Gastroenterology.
[13] Jonathan C. Cohen,et al. Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity , 2004, Hepatology.
[14] D. Amarapurkar,et al. Non‐alcoholic steatohepatitis in type 2 diabetes mellitus , 2004, Journal of gastroenterology and hepatology.
[15] H. El‐Serag,et al. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. , 2004, Gastroenterology.
[16] B. Neuschwander‐Tetri,et al. Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference , 2003, Hepatology.
[17] D. Joy,et al. Diagnosis of fatty liver disease: is biopsy necessary? , 2003, European journal of gastroenterology & hepatology.
[18] C. Ryan,et al. One hundred consecutive hepatic biopsies in the workup of living donors for right lobe liver transplantation , 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[19] A. Sanyal,et al. AGA technical review on nonalcoholic fatty liver disease. , 2002, Gastroenterology.
[20] G. Brandi,et al. Prevalence of and Risk Factors for Hepatic Steatosis in Northern Italy , 2000, Annals of Internal Medicine.
[21] K. Batts,et al. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis , 1999, Hepatology.
[22] M. Manns,et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. , 1999, Journal of hepatology.
[23] D. Kivlahan,et al. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. , 1998, Archives of internal medicine.
[24] P. Schmalbrock,et al. Introduction of fast MR imaging in the assessment of hepatic steatosis. , 1995, Magnetic resonance imaging.
[25] C. Tiribelli,et al. Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis , 1995, Journal of magnetic resonance imaging : JMRI.
[26] Thomas F. Babor,et al. Alcohol Use Disorders Identification Test , 1995 .
[27] A. Joseph,et al. Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease. , 1991, Clinical radiology.
[28] F. Schaffner,et al. Nonalcoholic fatty liver disease. , 1986, Progress in liver diseases.